Effect of High Cheese Consumption on Metabolic Syndrome Risk Factors

NCT02616471 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 168

Last updated 2018-08-31

No results posted yet for this study

Summary

The overall aim of the present research project is to examine whether consumption of high daily amounts of cheese, both high-fat and low-fat, affects risk markers of disease in a study population of men and women with metabolic syndrome risk factors.

It will be explored whether high-fat and/or low-fat cheese consumption can be regarded healthy to consume for at-risk populations (assessed by within-group comparisons from baseline values) and if low-fat or non-fat alternatives to high-fat cheese should continue to be recommended (assessed by between-group comparisons).

In addition, it will be assessed if cheese consumption affects women and men differently as suggested by observational data. The present research project will examine the health effects of cheese as a food product per se and not as a sum of single nutrients, knowing that the single components of cheese cannot be adequately placebo-matched. A relatively high daily intake of high-fat cheese will be compared to a similar intake of low-fat cheese and with a carbohydrate control.

Conditions

  • Metabolic Syndrome

Interventions

DIETARY_SUPPLEMENT

High-fat cheese

DIETARY_SUPPLEMENT

Low-fat cheese

DIETARY_SUPPLEMENT

No-cheese/carbohydrate

Sponsors & Collaborators

  • The Danish Dairy Research Foundation, Denmark

    collaborator OTHER
  • Dairy Research Institute

    collaborator OTHER
  • Dairy Farmers of Canada

    collaborator OTHER
  • Centre National Interprofessionel de l'Economie Laitière

    collaborator OTHER
  • Dairy Australia

    collaborator INDUSTRY
  • Nederlandse Zuivel Organisatie

    collaborator OTHER
  • University of Copenhagen

    lead OTHER

Principal Investigators

  • Arne Astrup, Prof, MD · Head of Department of Nutrition, Exercise and Sports

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-02-28
Primary Completion
2015-05-31
Completion
2015-05-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02616471 on ClinicalTrials.gov